Hereditary cancer

Individualized insights to guide personalized care

Our hereditary cancer panels, developed by Mayo Clinic oncologists and backed by genetic counselors, utilize next- generation sequencing to evaluate dozens of genes associated with cancer risk. Test results, analyzed by Mayo Clinic experts, enable precision insights for individuals identified with hereditary cancer syndromes and those who are not.

Our hereditary cancer panels provide family members with a deeper understanding of their risk for developing certain types of cancer, which can be helpful in planning for the future. Our comprehensive germline cancer analyses complement our somatic offerings, allowing for streamlined cancer evaluations in one laboratory.

News and updates

The latest

  1. The genetics of cancer. The National Cancer Institute at the National Institutes of Health. Updated August 17, 2022. Accessed July 10, 2023
  2. Samadder NJ, et. al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021 Feb 1;7(2):230-237. doi:10.1001/jamaoncol.2020.6252. Erratum in: JAMA Oncol. 2021 Feb 1;7(2):312. PMID: 33126242; PMCID: PMC7600058.

Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.